US approves Pfizer/biotech vaccine for children aged five to 11
The US has approved the Pfizer/BioNTech vaccine for children aged five to 11, clearing the way for millions of young Americans to get vaccinated.
The decision by Centers of Disease Control and Prevention (CDC) Director Rochelle Wolensky comes after careful consideration from US drug regulators.
The US is already giving the vaccine to those aged 12 and over. This approval affects some 28 million US children.